Mayo Clinic Labs
  • MayoACCESS
  • MayoLINK
  • Register
  • My Dashboard
Test Catalog
  • Algorithms
  • Download Test Catalog & Interpretive Handbook
  • New Tests
  • NY State Informed Consent Tests
  • Performing Locations
  • Referred Tests
  • Specialty Testing
  • Test Updates
Ordering & Results
  • Critical Values & Results
  • Custom Gene Ordering
  • Forms
  • LIS Resources
  • MayoACCESS Resources
  • MayoLINK Resources
  • Order Your First Test
  • Patient Information and Signature Forms
  • Request Additional Testing
  • Send Additional Specimen
Specimen Handling
  • Collection & Preparation
  • Dangerous Goods Training
  • Shipping & Courier Guides
  • Shipping Regulations
  • Supplies
Customer Service
  • Billing
  • Contact Us
  • FAQ
  • IT Updates
  • Operational Updates
  • Quality & Compliance
Education & Insights
  • Educational Resources
  • News
  • Outreach
  • Podcasts
  • Stories
  • Contact
  • Log Out
Insights
  • Education
  • News
  • Podcasting
  • Stories
A simpler path to answers for patients with mast cell activation syndrome featured image
A simpler path to answers for patients with mast cell activation syndrome

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

August 11, 2025
Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D. featured image
Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.
September 11, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss troublesome organisms making headlines.

Last chance to register for virtual phlebotomy workshop featured image
Last chance to register for virtual phlebotomy workshop
September 10, 2025

The registration deadline for Mayo Clinic Laboratories Education’s first-ever virtual phlebotomy workshop on Oct. 1 is fast approaching. Register today.

Join us on Oct. 29 for a SAAmplify-αSYN testing webinar featured image
Join us on Oct. 29 for a SAAmplify-αSYN testing webinar
September 8, 2025

Join us for a webinar exploring the revolutionary way SAAmplify™–αSYN testing, which is offered by Mayo Clinic Laboratories in collaboration with Amprion, is improving diagnostic accuracy for patients with neurodegenerative disorders.

Transforming the Laboratory Test Catalog Into a Strategic Asset featured image
Transforming the Laboratory Test Catalog Into a Strategic Asset
July 21, 2025

The laboratory test catalog is no longer just a reference list — it’s a strategic asset. By expanding its content, laboratories can improve satisfaction and experience.

A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon featured image
A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon
July 21, 2025

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.

A blue gloved hand picking up slides in a blue-tinted lab setting.
The Final Rounds
July 18, 2025

This episode marks the end of “Lab Medicine Rounds.” Host Justin Kreuter, M.D., reflects on the impact of the series and introduces an upcoming video-based[...]

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D. featured image
How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.
July 17, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event.

Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC featured image
Expanded Assay Better Identifies Hereditary Pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC
July 15, 2025

Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.

Join us for a virtual phlebotomy workshop featured image
Join us for a virtual phlebotomy workshop
July 14, 2025

Join us for Mayo Clinic Laboratories Education first-ever virtual phlebotomy workshop on Wednesday, Oct. 1.

Fingers holding a vial.
Streamlining lab visits: Can patient self-collected blood improve the phlebotomy experience?
September 10, 2025

PACE/State of FL - Presentation Recording Coming Soon - This presentation explores the distinctions between capillary and venous collection and compares home-based versus clinic-based sampling, with attention to delayed processing and shipping stability. 

Pancreatitis DNA image
Expanded Pancreatitis Gene Panel (PANGP)
July 8, 2025

Clinically relevant overview of key genetic factors, testing strategies, and post-result care.

Three people having a meeting.
Preventing Unnecessary Fireworks: Resolving Conflict in the Workplace
July 7, 2025

Conflict is a natural part of human interaction, and the workplace is not immune from that experience.  Through this microlearning, we'll explore how proper conflict[...]

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D. featured image
How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.
July 3, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed.

Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D. featured image
Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D.
July 1, 2025

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new assay measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

Lewy Body Dementia brain images
Neurodegenerative Diseases: Diagnostic Advancements
July 1, 2025

For healthcare professionals seeking to enhance their understanding of the assessment and treatment options for patients with neurodegenerative diseases.

View MoreView Less
Mayo Clinic Labs
Mayo Clinic Labs
  • Mayo Clinic
  • About us
  • BioPharma
  • Cardiovascular services
  • Newsroom
Resources
  • FAQ
  • Policies
  • Quality
  • Careers
  • Insights
  • Terms of use
  • Privacy statement
Accounts
  • Mayo account
  • MayoLINK
  • Register
  • Dashboard
  • Log out
Contacts
  • Contacts
  • Customer service
Facebook Twitter Instagram LinkedIn YouTube
© 1995–2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.